Compounds For Inhibiting Wip1, Prodrugs And Compositions Thereof, And Related Methods Read more about Compounds For Inhibiting Wip1, Prodrugs And Compositions Thereof, And Related Methods US Application 12/675,167Filed on 2010-02-25
COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS Read more about COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS European Patent08798994.3Filed on 2008-08-29
COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS Read more about COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS Canada2698094Filed on 2008-08-29
COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS Read more about COMPOUNDS FOR INHIBITING WIP1, PRODRUGS AND COMPOSITIONS THEREOF, AND RELATED METHODS Australia2008292910Filed on 2008-08-29
Alpha 1- 3 N- Galactosyltransferase with Altered Donor Specificities Read more about Alpha 1- 3 N- Galactosyltransferase with Altered Donor Specificities US Patent 8,425,901Filed on 2010-02-22
Beta 1,4 Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use Read more about Beta 1,4 Galactosyltransferases with Altered Donor and Acceptor Specificities, Compositions and Methods of Use US Patent 8,512,991Filed on 2010-02-22
Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions Read more about Diagnostic Tool For Diagnosing Benign Versus Malignant Thyroid Lesions US Patent 9,234,244Filed on 2008-08-27
Molecular-Based Methods of Cancer Diagnosis and Prognosis Read more about Molecular-Based Methods of Cancer Diagnosis and Prognosis Patent Cooperation TreatyPCT/US2010/024026Filed on 2010-02-12
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Italy02761818.0Filed on 2002-09-25
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. United Kingdom02761818.0Filed on 2002-09-25